Analysts Issue Forecasts for CVS Health FY2026 Earnings

CVS Health Co. (NYSE:CVS - Free Report) - Analysts at Cantor Fitzgerald issued their FY2026 earnings estimates for CVS Health in a report released on Monday, June 9th. Cantor Fitzgerald analyst S. James anticipates that the pharmacy operator will earn $6.82 per share for the year. Cantor Fitzgerald currently has a "Overweight" rating on the stock. The consensus estimate for CVS Health's current full-year earnings is $5.89 per share.

CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.63. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. The company had revenue of $94.59 billion during the quarter, compared to analysts' expectations of $93.07 billion. During the same period last year, the business earned $1.31 earnings per share. CVS Health's quarterly revenue was up 7.0% on a year-over-year basis.

A number of other research analysts have also recently commented on the company. Piper Sandler upped their price objective on CVS Health from $72.00 to $74.00 and gave the company an "overweight" rating in a report on Friday, March 21st. Leerink Partnrs upgraded CVS Health from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, February 12th. Morgan Stanley reiterated an "overweight" rating on shares of CVS Health in a report on Tuesday, April 15th. Royal Bank of Canada increased their price target on shares of CVS Health from $74.00 to $81.00 and gave the company an "outperform" rating in a research note on Monday, May 5th. Finally, Wolfe Research lifted their price target on shares of CVS Health from 67.00 to 70.00 and gave the stock an "overweight" rating in a research note on Tuesday, February 11th. Two investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $74.75.

CVS Health Price Performance

Shares of NYSE CVS traded up $0.72 during midday trading on Tuesday, hitting $64.98. The stock had a trading volume of 2,512,687 shares, compared to its average volume of 10,731,402. The company has a quick ratio of 0.60, a current ratio of 0.81 and a debt-to-equity ratio of 0.80. The stock has a 50 day simple moving average of $65.06 and a 200-day simple moving average of $60.01. CVS Health has a 1 year low of $43.56 and a 1 year high of $72.51. The company has a market capitalization of $82.20 billion, a PE ratio of 17.75, a P/E/G ratio of 0.98 and a beta of 0.56.

Hedge Funds Weigh In On CVS Health

Institutional investors and hedge funds have recently bought and sold shares of the stock. Norges Bank acquired a new position in CVS Health in the fourth quarter worth about $839,574,000. Capital World Investors grew its stake in shares of CVS Health by 26.6% in the fourth quarter. Capital World Investors now owns 61,039,777 shares of the pharmacy operator's stock worth $2,739,927,000 after purchasing an additional 12,819,148 shares in the last quarter. Davis Selected Advisers increased its holdings in shares of CVS Health by 2,998.1% during the fourth quarter. Davis Selected Advisers now owns 11,385,950 shares of the pharmacy operator's stock valued at $511,115,000 after purchasing an additional 11,018,438 shares during the period. Dodge & Cox grew its position in CVS Health by 11.2% in the 4th quarter. Dodge & Cox now owns 70,105,899 shares of the pharmacy operator's stock valued at $3,147,054,000 after buying an additional 7,075,209 shares in the last quarter. Finally, Pzena Investment Management LLC raised its position in shares of CVS Health by 49.3% during the 4th quarter. Pzena Investment Management LLC now owns 19,610,579 shares of the pharmacy operator's stock worth $880,319,000 after buying an additional 6,475,271 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company's stock.

Insider Buying and Selling

In other CVS Health news, Director Guy P. Sansone bought 1,570 shares of CVS Health stock in a transaction that occurred on Thursday, June 5th. The shares were purchased at an average cost of $63.70 per share, for a total transaction of $100,009.00. Following the completion of the transaction, the director now owns 12,007 shares of the company's stock, valued at $764,845.90. This represents a 15.04% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.22% of the stock is owned by company insiders.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, May 1st. Stockholders of record on Tuesday, April 22nd were issued a dividend of $0.665 per share. The ex-dividend date of this dividend was Tuesday, April 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.09%. CVS Health's dividend payout ratio (DPR) is presently 63.48%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.